Toggle navigation
Home
Search
Services
Blog
Contact
About
OBI-1 - 305 Rescue theraphy, cong &acquired, all else failed
Bergman, Garrett E.
Octagen Corporation, Blue Bell, PA, United States
Search 11 grants from Garrett Bergman
Search grants from Octagen Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Xavier RCMI Renewal Application-Overall
Neuroimaging for Early Diagnosis of Manganese Toxicity in Humans and Rodents
Mechanisms of Vascular Dysfunction in Vibration Injury
Specificity - Receptor-Mediated Phosphoinositide Turnover
Regional Differences in Ventricular Electrical Activity
Recently added grants:
Pulmonary Epithelial TRPV3 and Wood Smoke Injury
Mechanisms of environmental epigenetic disruption and memory of exposure in germ cells
Mechanisms of AHR Metabolic Toxicity
Structured nonparametric methods for mixtures of exposures
Human Immunotoxicity of Developmental PCB Exposure
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44HL064497-04
Application #
7149845
Study Section
Special Emphasis Panel (ZRG1)
Project Start
2005-08-01
Project End
2008-07-31
Budget Start
Budget End
Support Year
4
Fiscal Year
2005
Total Cost
Indirect Cost
Institution
Name
Octagen Corporation
Department
Type
DUNS #
052982852
City
Blue Bell
State
PA
Country
United States
Zip Code
19422
Related projects
Comments
Be the first to comment on Garrett Bergman's grant